Facing the threat of an increasingly securitised and repressive EU approach to drug policy, harm reductionists across the continent and within the bloc's institutions must deepen solidarity and resistance in defence of health and rights based responses.
Minnesota's drug policy reforms, particularly on cannabis and harm reduction represent a step in the right direction; but the continued use of punitive measures and the lack of safe supply programs are misguided.
Ann Fordham (IDPC Executive Director) analyses the key takeaways and significance of the OHCHR's latest report, noting how its call for transformative change includes an unprecedented recommendation to consider the responsible regulation of illegal drug markets.
After seven years of service to the Board of Directors, IDPC bids farewell to outgoing member and harm reduction champion, Donald MacPherson; with Vicki Hanson and Smriti Rana ensuring continued leadership.
The latest Human Rights Council resolution on the human rights implications of drug policy represents the most ambitious and progressive resolution on the matter to date, and should influence the outcome of the upcoming 2024 mid-term review of the 2019 Ministerial Declaration.